Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 17,476–17,500 of 27,380 studies, newest first · page 700 of 1096.

November 2014 25

  1. 2014-11-27

    Bilingualism and cognition

    ✓ Peer-reviewed Risk factors Bilingualism Language and Cognition

    Key finding: To understand the variability and inconsistencies in results with bilingualism, I analyze concepts of executive function and cognitive reserve and examine the range of factors (such as active video game playing, education, musical training, and aerobic exercise) that are known to correlate with or to improve executive function. +1 more finding

  2. 2014-11-26

    Peptide Vaccines for Hypertension and Diabetes Mellitus

    ✓ Peer-reviewed Risk factors Vaccines

    Key finding: In our therapeutic vaccines against hypertension, the target is angiotensin II (Ang II) and induced anti-Ang II antibodies could efficiently ameliorate high blood pressure. +4 more findings

  3. 2014-11-25

    Preventing delirium: should non-pharmacological, multicomponent interventions be used? A systematic review and meta-analysis of the literature

    ✓ Peer-reviewed Clinical safety Age and ageing

    Key finding: A total of 21,788 citations were screened, and seven studies of diverse quality were included in the review, comprising 1,691 participants. +2 more findings

  4. 2014-11-22

    Medical genetics-based drug repurposing for Alzheimer's disease

    ✓ Peer-reviewed Drug development Brain research bulletin

    Key finding: In vitro and in vivo experiments revealed that four drugs, all of which are angiotensin-converting enzyme (ACE) inhibitors, had potential to treat AD.

  5. 2014-11-21
  6. 2014-11-21

    Prevalence of mixed pathologies in the aging brain

    ✓ Peer-reviewed Lewy body dementia Alzheimer's research & therapy

    Key finding: In summary, community-based neuropathology studies have shown that complex constellations of underlying pathologies may lead to cognitive decline, and that the number of possible combinations increases in the aging brain.

  7. 2014-11-20

    Multimodal neuroimaging feature learning for multiclass diagnosis of Alzheimer's disease

    ✓ Peer-reviewed Digital health tools IEEE transactions on bio-medical engineering

    Key finding: Compared to the previous state-of-the-art workflows, our method is capable of fusing multimodal neuroimaging features in one setting and has the potential to require less labeled data.

  8. 2014-11-20

    Multimodality imaging of Alzheimer disease and other neurodegenerative dementias

    ✓ Peer-reviewed Biomarkers Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Key finding: Neurodegenerative diseases, such as Alzheimer disease, result in cognitive decline and dementia and are a leading cause of mortality in the growing elderly population. +1 more finding

  9. 2014-11-19

    Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model

    ✓ Peer-reviewed Genetics Nature communications

    Key finding: We find that astrocytic hyperactivity, consisting of single-cell transients and calcium waves, is most pronounced in reactive astrogliosis around plaques and is sometimes associated with local blood flow changes. +1 more finding

  10. 2014-11-19

    Obesity and cognitive decline: role of inflammation and vascular changes

    ✓ Peer-reviewed How common it is Frontiers in neuroscience

    Key finding: Numerous studies have demonstrated that both obesity and metabolic disorders are associated with poorer cognitive performance, cognitive decline, and dementia.

  11. 2014-11-18

    Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism

    ✓ Peer-reviewed Treatments Molecular neurodegeneration

    Key finding: This may require a better in depth understanding of the cascade. +4 more findings

  12. 2014-11-18

    Hippocampal structural and functional changes associated with electroconvulsive therapy response

    ✓ Peer-reviewed Hippocampus size on brain scans Translational psychiatry

    Key finding: Longitudinal changes in functional connectivity of hippocampal regions and volumes of hippocampal subfields were compared with reductions in ratings of depressive symptoms. +1 more finding

  13. 2014-11-18

    Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers

    ✓ Peer-reviewed Prevention trials PLoS medicine

    Key finding: The overall effect size (Hedges' g, random effects model) for CCT versus control was small and statistically significant, g = 0.22 (95% CI 0.15 to 0.29). +3 more findings

  14. 2014-11-15

    Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: This study examined the relationship between self- versus informant-report of functional ability, and how those reports relate to objective disease measures across the disease spectrum (i.e. cognitively normal, MCI, Alzheimer's disease). +1 more finding

  15. 2014-11-15

    Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Inexpensive, non-invasive tools for assessing Alzheimer-type pathophysiologies are needed.

  16. 2014-11-14

    Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease

    ✓ Peer-reviewed Treatments Molecular neurodegeneration

    Key finding: Compelling evidence suggests that soluble amyloid-β peptide (Aβ) oligomers induce synaptic loss in AD. +2 more findings

  17. 2014-11-12

    Polyunsaturated fatty acids and their metabolites in brain function and disease

    ✓ Peer-reviewed Risk factors Nature reviews. Neuroscience

    Key finding: These include the polyunsaturated fatty acids (PUFAs) arachidonic acid and docosahexaenoic acid, which are largely esterified to the phospholipid cell membrane. +4 more findings

  18. 2014-11-11

    Dementia drug consumption in the Basque Country between 2006 and 2011

    ✓ Peer-reviewed Treatments Neurologia (Barcelona, Spain)

    Key finding: Consumption increased by 49.72% between 2006 and 2011. +4 more findings

  19. 2014-11-11

    'The clocks that time us'--circadian rhythms in neurodegenerative disorders

    ✓ Peer-reviewed Risk factors Nature reviews. Neurology

    Key finding: Clinical studies and experiments in animal models of neurodegenerative disorders have revealed the progressive nature of circadian dysfunction throughout the course of neurodegeneration, and suggest strategies for the restoration of circadian rhythmicity involving behavioural and pharmacological interventions that target the sleep-wake cycle.

  20. 2014-11-11

    TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices

    ✓ Peer-reviewed TREM2 and immune genetics Brain pathology (Zurich, Switzerland)

    Key finding: Several studies have shown that TREM2 gene variant rs75932628-T increased the risks for Alzheimer's disease (AD), Parkinson's disease, frontotemporal dementia and amyotrophic lateral sclerosis. +3 more findings

  21. 2014-11-11

    The overlap between vascular disease and Alzheimer's disease--lessons from pathology

    ✓ Peer-reviewed Lewy body dementia BMC medicine

    Key finding: The most frequent vascular pathologies in the aging brain and in AD are cerebral amyloid angiopathy and small vessel disease. +4 more findings

  22. 2014-11-11

    Incidence of and risk factors for Alzheimer's disease and mild cognitive impairment in Korean elderly

    ✓ Peer-reviewed Disparities Dementia and geriatric cognitive disorders

    Key finding: Strategies to control modifiable risk factors should be implemented to decrease the incidence of AD. +2 more findings

  23. 2014-11-10

    Functional connectivity dynamics: modeling the switching behavior of the resting state

    ✓ Peer-reviewed Brain scans and imaging NeuroImage

    Key finding: Most computational studies, however, did not address the prominent non-stationarity in resting state FC, which may result in large intra- and inter-subject variability and thus preclude an accurate individual predictability.

  24. 2014-11-10

    Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter

    ✓ Peer-reviewed Risk genes beyond APOE FASEB journal : official publication of the Federation of American Societies for Experimental Biology

    Key finding: In this study, activation of the Wnt pathway by overexpression of the agonist Wnt3a or β-catenin or by inhibition of glycogen kinase synthase-3 in N2a cells resulted in a reduction in Aβ levels and in the activity and expression of BACE1 (β-APP cleaving enzyme). +3 more findings

  25. 2014-11-08

    The need for palliative care in Ireland: a population-based estimate of palliative care using routine mortality data, inclusive of nonmalignant conditions

    ✓ Peer-reviewed End-of-life care Journal of pain and symptom management

    Key finding: Future palliative care policy decisions in Ireland must consider the rapidly aging Irish population with the accompanying increase in deaths from cancer, dementia, and neurodegenerative disease and associated palliative care need.

Browse the library by subject, with the full score breakdown →